Vimarsana
Biggest News Aggregation in the World

Human Data Science News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Human Data Science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Human Data Science Today - Breaking & Trending Today

As Biden makes his case for reelection, the cost of insulin takes center stage - Vimarsana News

As Biden makes his case for reelection, the cost of insulin takes center stage

“Biden is doing better with older voters than he anticipated, and I think his Medicare policies are an important part of that,” said Geoff Garin, a pollster for the Biden campaign.

Auditing the prescription drug Consumer Price Index in a changing marketplace - Vimarsana News

Auditing the prescription drug Consumer Price Index in a changing marketplace

Richard G. Frank, Ernst R. Berndt, and Andrew L. Hicks analyze how the treatment of specialty drugs in the CPI affects growth in measured prescription drug prices and urge caution in interpreting the prescription drug component of the CPI as a comprehensive reflection of price growth.

Altron HealthTech, Dischem Oncology collaborate on standardising Electronic Health Record technology - Vimarsana News

Altron HealthTech, Dischem Oncology collaborate on standardising Electronic Health Record technology

The partnership will allow oncology practitioners to improve chemotherapy prescription management and treatment efficiencies.

IQVIA report sizes up trends in new drug launches, clinical trials, R&D funding - Vimarsana News

IQVIA report sizes up trends in new drug launches, clinical trials, R&D funding

R&D funding levels have rebounded in 2023 after a steep decline from the peak seen in 2020-21, per IQVIA's report.

Global Biopharma R&D Boasts Increased Funding, Productivity and Product Launches in 2023, says IQVIA Institute Report - Vimarsana News

Global Biopharma R&D Boasts Increased Funding, Productivity and Product Launches in 2023, says IQVIA Institute Report

Clinical development productivity rose in 2023, primarily due to an improvement in the composite success rate, a function of phases successfully completed in the year, which rose to 10.8%. This was...